Even after publication of ECASS II, the latest paper in a series of large, placebo-controlled studies on thrombolysis in acute ischaemic stroke, there is still uncertainty as to what the best clinical endpoint(s) is (are) in trial design for reliably identifying significant differences between treatment groups.
Verordnung (EG, Euratom) Nr. #/# des Rates vom #. Juni # über die Haushaltsordnung für den Gesamthaushaltsplan der Europäischen Gemeinschaften (ABl. L # vom #.#.#, S. #), insbesondere Artikel # Absatzspringer springer